ResearcherChristian-Albrechts-Universität zu KielNo recent work listed

David I. Radke

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-9189-5747; OpenAlex author ID A5039393758. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2018: 1 paper

Papers 1

Downregulation of TRAIL-Receptor 1 Increases TGFβ Type II Receptor Expression and TGFβ Signalling Via MicroRNA-370-3p in Pancreatic Cancer Cells. Co-author DOI 10.3390/cancers10110399 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hendrik Ungefroren · 1 shared paper, 2018 · strength 0.10
- Paper Downregulation of TRAIL-Receptor 1 Increases TGFβ Type II Receptor Expression and TGFβ Signalling Via MicroRNA-370-3p i… DOI 10.3390/cancers10110399 ↗
Anna Trauzold · 1 shared paper, 2018 · strength 0.10
- Paper Downregulation of TRAIL-Receptor 1 Increases TGFβ Type II Receptor Expression and TGFβ Signalling Via MicroRNA-370-3p i… DOI 10.3390/cancers10110399 ↗
Qi Ling · 1 shared paper, 2018 · strength 0.10
- Paper Downregulation of TRAIL-Receptor 1 Increases TGFβ Type II Receptor Expression and TGFβ Signalling Via MicroRNA-370-3p i… DOI 10.3390/cancers10110399 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.